On the other hand, we found that higher levels of anti-Spike and anti-RBD IgA, and lower levels of anti-NP IgG and IgA characterize fatal outcomes, suggesting these antibody features as predictors of death from COVID-19. Here, CD79A is linked to COVID-19.